Hematopoietic dysfunction is a general term that is considered a broad category of hematologic dysfunction, and leukemia is not included in the category of hematopoietic dysfunction.
Hematopoietic dysfunction is a manifestation of diminished, low bone marrow hematopoiesis, a condition in which the peripheral blood triad is reduced due to the inability to meet the normal metabolism and release of blood cells in the peripheral blood.
The most common hematopoietic disorder is aplastic anemia, which also occurs with abnormal bone marrow hyperplasia and myelofibrosis.
Aplastic anemia is a syndrome of hematopoietic stem cell failure in the bone marrow, whereas leukemia is a disease of malignant cloning of hematopoietic stem cells; they are both blood disorders but have different causes and pathogenesis and are not the same disease.
The main symptoms of leukemia are fever, anemia, generalized bone and joint pain, and can present with systemic organ invasion, resulting in multiple organ failure or even death in severe cases.
The main symptoms of aplastic anemia are anemia, infection and hemorrhage, mainly in the respiratory system, circulatory system and brain, often with sepsis.
Patients with hematopoietic dysfunction can be treated with bone marrow transplantation, and the younger the age of onset, the earlier the treatment and the better the outcome.